AAAAAA

   
Results: 1-15 |
Results: 15
PHASE-I AND PHARMACOLOGICAL STUDY OF CI-980, A NOVEL SYNTHETIC ANTIMICROTUBULE AGENT
Authors: ROWINSKY EK LONG GS NOE DA GROCHOW LB BOWLING MK SARTORIUS SE DONEHOWER RC
Citation: Ek. Rowinsky et al., PHASE-I AND PHARMACOLOGICAL STUDY OF CI-980, A NOVEL SYNTHETIC ANTIMICROTUBULE AGENT, Clinical cancer research, 3(3), 1997, pp. 401-407
PHASE-I STUDY OF PACLITAXEL ON A 3-HOUR SCHEDULE FOLLOWED BY CARBOPLATIN IN UNTREATED PATIENTS WITH STAGE-IV NONSMALL CELL LUNG-CANCER
Authors: ROWINSKY EK FLOOD WA SARTORIUS SE BOWLING KM ETTINGER DS
Citation: Ek. Rowinsky et al., PHASE-I STUDY OF PACLITAXEL ON A 3-HOUR SCHEDULE FOLLOWED BY CARBOPLATIN IN UNTREATED PATIENTS WITH STAGE-IV NONSMALL CELL LUNG-CANCER, Investigational new drugs, 15(2), 1997, pp. 129-138
A PHASE-I AND PHARMACOLOGICAL STUDY OF TOPOTECAN INFUSED OVER 30 MINUTES FOR 5 DAYS IN PATIENTS WITH REFRACTORY ACUTE-LEUKEMIA
Authors: ROWINSKY EK KAUFMANN SH BAKER SD MILLER CB SARTORIUS SE BOWLING MK CHEN TL DONEHOWER RC GORE SD
Citation: Ek. Rowinsky et al., A PHASE-I AND PHARMACOLOGICAL STUDY OF TOPOTECAN INFUSED OVER 30 MINUTES FOR 5 DAYS IN PATIENTS WITH REFRACTORY ACUTE-LEUKEMIA, Clinical cancer research, 2(12), 1996, pp. 1921-1930
PHASE-I AND PHARMACOLOGICAL STUDY OF HIGH-DOSES OF THE TOPOISOMERASE-I INHIBITOR TOPOTECAN WITH GRANULOCYTE-COLONY-STIMULATING FACTOR IN PATIENTS WITH SOLID TUMORS
Authors: ROWINSKY EK GROCHOW LB SARTORIUS SE BOWLING MK KAUFMANN SH PEEREBOOM D DONEHOWER RC
Citation: Ek. Rowinsky et al., PHASE-I AND PHARMACOLOGICAL STUDY OF HIGH-DOSES OF THE TOPOISOMERASE-I INHIBITOR TOPOTECAN WITH GRANULOCYTE-COLONY-STIMULATING FACTOR IN PATIENTS WITH SOLID TUMORS, Journal of clinical oncology, 14(4), 1996, pp. 1224-1235
SEQUENCES OF TOPOTECAN AND CISPLATIN - PHASE-I, PHARMACOLOGICAL, AND IN-VITRO STUDIES TO EXAMINE SEQUENCE DEPENDENCE
Authors: ROWINSKY EK KAUFMANN SH BAKER SD GROCHOW LB CHEN TL PEEREBOOM D BOWLING MK SARTORIUS SE ETTINGER DS FORASTIERE AA DONEHOWER RC
Citation: Ek. Rowinsky et al., SEQUENCES OF TOPOTECAN AND CISPLATIN - PHASE-I, PHARMACOLOGICAL, AND IN-VITRO STUDIES TO EXAMINE SEQUENCE DEPENDENCE, Journal of clinical oncology, 14(12), 1996, pp. 3074-3084
PHARMACOKINETIC, ORAL BIOAVAILABILITY, AND SAFETY STUDY OF FLUOROURACIL IN PATIENTS TREATED WITH 776C85, AN INACTIVATOR OF DIHYDROPYRIMIDINE DEHYDROGENASE
Authors: BAKER SD KHOR SP ADJEI AA DOUCETTE M SPECTOR T DONEHOWER RC GROCHOW LB SARTORIUS SE NOE DA HOHNEKER JA ROWINSKY EK
Citation: Sd. Baker et al., PHARMACOKINETIC, ORAL BIOAVAILABILITY, AND SAFETY STUDY OF FLUOROURACIL IN PATIENTS TREATED WITH 776C85, AN INACTIVATOR OF DIHYDROPYRIMIDINE DEHYDROGENASE, Journal of clinical oncology, 14(12), 1996, pp. 3085-3096
THE EFFECTS OF FOOD AND DIVIDED DOSING ON THE BIOAVAILABILITY OF ORALVINORELBINE
Authors: ROWINSKY EK LUCAS VS HSIEH ALY WARGIN WA HOHNEKER JA LUBEJKO B SARTORIUS SE DONEHOWER RC
Citation: Ek. Rowinsky et al., THE EFFECTS OF FOOD AND DIVIDED DOSING ON THE BIOAVAILABILITY OF ORALVINORELBINE, Cancer chemotherapy and pharmacology, 39(1-2), 1996, pp. 9-16
PHASE-I STUDY OF PACLITAXEL AS A 3-HOUR INFUSION FOLLOWED BY CARBOPLATIN IN UNTREATED PATIENTS WITH STAGE-IV NON-SMALL-CELL LUNG-CANCER
Authors: ROWINSKY EK FLOOD WA SARTORIUS SE BOWLING MK WAGNER J ETTINGER DS
Citation: Ek. Rowinsky et al., PHASE-I STUDY OF PACLITAXEL AS A 3-HOUR INFUSION FOLLOWED BY CARBOPLATIN IN UNTREATED PATIENTS WITH STAGE-IV NON-SMALL-CELL LUNG-CANCER, Seminars in oncology, 22(4), 1995, pp. 48-54
PHARMACOKINETIC, BIOAVAILABILITY, AND FEASIBILITY STUDY OF ORAL VINORELBINE IN PATIENTS WITH SOLID TUMORS
Authors: ROWINSKY EK NOE DA TRUMP DL WINER EP LUCAS VS WARGIN WA HOHNEKER JA LUBEJKO B SARTORIUS SE ETTINGER DS DONEHOWER RC
Citation: Ek. Rowinsky et al., PHARMACOKINETIC, BIOAVAILABILITY, AND FEASIBILITY STUDY OF ORAL VINORELBINE IN PATIENTS WITH SOLID TUMORS, Journal of clinical oncology, 12(9), 1994, pp. 1754-1763
PERIPHERAL NEUROPATHY FROM TAXOL AND CISPLATIN COMBINATION CHEMOTHERAPY - CLINICAL AND ELECTROPHYSIOLOGICAL STUDIES
Authors: CHAUDHRY V ROWINSKY EK SARTORIUS SE DONEHOWER RC CORNBLATH DR
Citation: V. Chaudhry et al., PERIPHERAL NEUROPATHY FROM TAXOL AND CISPLATIN COMBINATION CHEMOTHERAPY - CLINICAL AND ELECTROPHYSIOLOGICAL STUDIES, Annals of neurology, 35(3), 1994, pp. 304-311
PHASE-I AND PHARMACOLOGICAL STUDY OF THE NOVEL TOPOISOMERASE-I INHIBITOR 1-PIPERIDINO)-1-PIPERIDINO]CARBONYLOXYCAMPTOTHECIN (CPT-11) ADMINISTERED AS A 90-MINUTE INFUSION EVERY 3 WEEKS
Authors: ROWINSKY EK GROCHOW LB ETTINGER DS SARTORIUS SE LUBEJKO BG CHEN TL ROCK MK DONEHOWER RC
Citation: Ek. Rowinsky et al., PHASE-I AND PHARMACOLOGICAL STUDY OF THE NOVEL TOPOISOMERASE-I INHIBITOR 1-PIPERIDINO)-1-PIPERIDINO]CARBONYLOXYCAMPTOTHECIN (CPT-11) ADMINISTERED AS A 90-MINUTE INFUSION EVERY 3 WEEKS, Cancer research, 54(2), 1994, pp. 427-436
PHASE-I AND PHARMACOLOGICAL STUDY OF PACLITAXEL AND CISPLATIN WITH GRANULOCYTE-COLONY-STIMULATING FACTOR - NEUROMUSCULAR TOXICITY IS DOSE-LIMITING
Authors: ROWINSKY EK CHAUDHRY V FORASTIERE AA SARTORIUS SE ETTINGER DS GROCHOW LB LUBEJKO BG CORNBLATH DR DONEHOWER RC
Citation: Ek. Rowinsky et al., PHASE-I AND PHARMACOLOGICAL STUDY OF PACLITAXEL AND CISPLATIN WITH GRANULOCYTE-COLONY-STIMULATING FACTOR - NEUROMUSCULAR TOXICITY IS DOSE-LIMITING, Journal of clinical oncology, 11(10), 1993, pp. 2010-2020
NURSING CONSIDERATIONS IN PACLITAXEL (TAXOL(R)) ADMINISTRATION
Authors: LUBEJKO BG SARTORIUS SE
Citation: Bg. Lubejko et Se. Sartorius, NURSING CONSIDERATIONS IN PACLITAXEL (TAXOL(R)) ADMINISTRATION, Seminars in oncology, 20(4), 1993, pp. 26-30
PHASE-I AND PHARMACOLOGICAL STUDY OF THE PULMONARY CYTOTOXIN 4-IPOMEANOL ON A SINGLE DOSE SCHEDULE IN LUNG-CANCER PATIENTS - HEPATOTOXICITYIS DOSE LIMITING IN HUMANS
Authors: ROWINSKY EK NOE DA ETTINGER DS CHRISTIAN MC LUBEJKO BG FISHMAN EK SARTORIUS SE BOYD MR DONEHOWER RC
Citation: Ek. Rowinsky et al., PHASE-I AND PHARMACOLOGICAL STUDY OF THE PULMONARY CYTOTOXIN 4-IPOMEANOL ON A SINGLE DOSE SCHEDULE IN LUNG-CANCER PATIENTS - HEPATOTOXICITYIS DOSE LIMITING IN HUMANS, Cancer research, 53(8), 1993, pp. 1794-1801
PHASE-I AND PHARMACOLOGICAL STUDY OF TOPOTECAN - A NOVEL TOPOISOMERASE-I INHIBITOR
Authors: ROWINSKY EK GROCHOW LB HENDRICKS CB ETTINGER DS FORASTIERE AA HUROWITZ LA MCGUIRE WP SARTORIUS SE LUBEJKO BG KAUFMANN SH DONEHOWER RC
Citation: Ek. Rowinsky et al., PHASE-I AND PHARMACOLOGICAL STUDY OF TOPOTECAN - A NOVEL TOPOISOMERASE-I INHIBITOR, Journal of clinical oncology, 10(4), 1992, pp. 647-656
Risultati: 1-15 |